Recent studies reveal promising outcomes for discontinuing TKI therapy in select patients with Philadelphia ...

Stella Stabouli; Sofia Papakatsika; Vasilios Kotsis Disclosures Expert Rev Cardiovasc Ther. 2010;8 (11):1559-1565.

Clin Lipidology. 2010;5(4):477-480. Eprotirome is a liver and thyroid hormone receptor-b-selective thyromimetic compound. In patients receiving statin therapy, eprotirome led to a further 22–32% ...

The T3 (triiodothyronine) and T4 (thyroxine) hormones are which are very important for controlling the metabolic rate as well as the use of energy. These are released by our Thyroid glands.